PubMed=6372095; DOI=10.1126/science.6372095
Alfred M. Rogan, Thomas C. Hamilton, Robert C. Young, Raymond W. Klecker Jr., Robert F. Ozols;
Reversal of adriamycin resistance by verapamil in human ovarian cancer.
Science 224:994-996(1984)

PubMed=6385258
Thomas C. Hamilton, Robert C. Young, Robert F. Ozols;
Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.
Semin. Oncol. 11:285-298(1984)

PubMed=3930572; DOI=10.1172/JCI112082; PMCID=PMC424036
Robert Pirker, David J.P. FitzGerald, Thomas C. Hamilton, Robert F. Ozols, Walter Joseph Laird, Arthur Edward Frankel, Mark C. Willingham, Ira Pastan;
Characterization of immunotoxins active against ovarian cancer cell lines.
J. Clin. Invest. 76:1261-1267(1985)

PubMed=2307530; DOI=10.1002/ijc.2910450306
Russell J. Schilder, Lemuel Hall, Anne Monks, Laura M. Handel, Albert J. Fornace Jr., Robert F. Ozols, Antonio Fojo, Thomas C. Hamilton;
Metallothionein gene expression and resistance to cisplatin in human ovarian cancer.
Int. J. Cancer 45:416-422(1990)

PubMed=1348364; DOI=10.1073/pnas.89.7.3070; PMCID=PMC48805
Andrew Kent Godwin, Alton Meister, Peter J. O'Dwyer, Chin-Shiou Huang, Thomas C. Hamilton, Mary E. Anderson;
High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.
Proc. Natl. Acad. Sci. U.S.A. 89:3070-3074(1992)

PubMed=9041185
Steven W. Johnson, Paul B. Laub, Jacqueline S. Beesley, Robert F. Ozols, Thomas C. Hamilton;
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.
Cancer Res. 57:850-856(1997)

PubMed=22710073; DOI=10.1016/j.ygyno.2012.06.017; PMCID=PMC3432677
Christopher T. Korch, Monique A. Spillman, Twila A. Jackson, Britta M. Jacobsen, Susan K. Murphy, Bruce Arthur Lessey, Virgil Craig Jordan, Andrew Peter Bradford;
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination.
Gynecol. Oncol. 127:241-248(2012)